- Home
- SYBX vs SFHG Comparison
SYBX vs SFHG Comparison
Compare SYBX & SFHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBX
- SFHG
- Stock Information
- Founded
- SYBX N/A
- SFHG 1993
- Country
- SYBX United States
- SFHG Hong Kong
- Employees
- SYBX N/A
- SFHG N/A
- Industry
- SYBX Biotechnology: Pharmaceutical Preparations
- SFHG Publishing
- Sector
- SYBX Health Care
- SFHG Consumer Discretionary
- Exchange
- SYBX Nasdaq
- SFHG Nasdaq
- Market Cap
- SYBX 13.6M
- SFHG 16.2M
- IPO Year
- SYBX N/A
- SFHG 2024
- Fundamental
- Price
- SYBX $1.26
- SFHG $0.72
- Analyst Decision
- SYBX
- SFHG
- Analyst Count
- SYBX 0
- SFHG 0
- Target Price
- SYBX N/A
- SFHG N/A
- AVG Volume (30 Days)
- SYBX 7.8K
- SFHG 47.2K
- Earning Date
- SYBX 08-07-2025
- SFHG 07-07-2025
- Dividend Yield
- SYBX N/A
- SFHG N/A
- EPS Growth
- SYBX N/A
- SFHG N/A
- EPS
- SYBX 0.21
- SFHG N/A
- Revenue
- SYBX N/A
- SFHG $19,760,935.00
- Revenue This Year
- SYBX N/A
- SFHG N/A
- Revenue Next Year
- SYBX N/A
- SFHG N/A
- P/E Ratio
- SYBX $5.82
- SFHG N/A
- Revenue Growth
- SYBX N/A
- SFHG 30.89
- 52 Week Low
- SYBX $0.90
- SFHG $0.55
- 52 Week High
- SYBX $1.88
- SFHG $24.00
- Technical
- Relative Strength Index (RSI)
- SYBX 52.81
- SFHG N/A
- Support Level
- SYBX $1.17
- SFHG N/A
- Resistance Level
- SYBX $1.27
- SFHG N/A
- Average True Range (ATR)
- SYBX 0.04
- SFHG 0.00
- MACD
- SYBX -0.01
- SFHG 0.00
- Stochastic Oscillator
- SYBX 40.00
- SFHG 0.00
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
About SFHG Samfine Creation Holdings Group Limited Ordinary Share
Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.